Weekly Pharma & Life Sciences News Round-Up: 25th – 29th July

A round-up of the latest news from the Life Science industry; including news from the Pharmaceutical, Clinical Research, Biotechnology and Medical Device sectors from 25^th-29^th July.

Scotland at forefront of ‘gamechanger’ €6m project to improve bowel cancer diagnosis

Scottish health researchers are at the forefront of a new €6m project to make Artificial Intelligence-assisted (AI) capsule endoscopy a part of future bowel cancer diagnostics.

Novotech’s flexible work policy is finalist in best workplace flexibility program ‘Excellence Award 2022’

Novotech, the leading Asia Pacific biotech specialist CRO with expanded services in the US, has been recognised for its innovative approach to workplace flexibility.

Pleco Therapeutics announces expansion with the incorporation of a U.S. subsidiary and the appointment of Michael Stalhamer as President

Pleco Therapeutics BV announces its expansion, with the incorporation of Pleco Therapeutics USA, Inc., alongside the appointment of Michael Stalhamer as its President and first employee.

General Internal Medicine specialty pilots launched by Health Education England

A new General Internal Medicine (GIM) specialty has been launched by Health Education England (HEE) to address the growing need for physicians who can deliver care for a range of complex conditions.

NeoPhore enters three year research collaboration with world leading oncologist’s lab at major US cancer center

NeoPhore Limited, a small molecule neoantigen immuno-oncology company, announces that it has entered a three-year research collaboration agreement with Memorial Sloan Kettering Cancer Center (MSK) in New York, USA.

Velocity Clinical Research begins European expansion with German site acquisition

Velocity Clinical Research, the leading integrated research site organisation, announces it has acquired its first European site, Clinical Research Hamburg, in Germany for an undisclosed amount.

PCI Pharma Services announces multi-million dollar expansion to UK manufacturing facility to meet growing demand for global high potent manufacturing services supporting oncology treatments

PCI Pharma Services (PCI), announces a significant expansion of its world-class facility in Tredegar, Wales, UK, designed to help keep pace with the market growth of powerful, targeted oncology therapies.

Labcorp to spin off Clinical Development business

Labcorp announces that its Board of Directors has authorized the Company to pursue a spin-off of the Company’s wholly owned Clinical Development business to Labcorp shareholders through a tax-free transaction.

Thermo Fisher Scientific showcases new clinical and research lab solutions at AACC 2022

Thermo Fisher Scientific Inc., the world leader in serving science, is showcasing innovative diagnostic technologies, assays and a complement of solutions for researchers developing new diagnostics.

Labcorp earns top score on 2022 Disability Equality Index

Labcorp announces that it scored 100, the highest score possible, on the 2022 Disability Equality Index (DEI), a comprehensive benchmarking tool for measuring disability inclusion in the workplace.

Biotest AG: Biotest grants Renate & Hans Schleussner Research Award for the first time

Dr. Philipp Kolb from the Institute of Virology at the University of Freiburg is the first winner of the Renate & Hans Schleussner Research Award.

Terumo Blood and Cell Technologies collaborates with Eliaz Therapeutics in the development and commercialization of a novel therapeutic apheresis treatment for acute kidney injury (AKI)

Acute kidney injury (AKI) and sepsis-induced acute kidney injury (S-AKI) are life-threatening conditions, with many patients dying and others left with long-term kidney damage requiring lifelong dialysis and resulting in early death.

Valo Therapeutics acquires PeptiCHIP technology enabling rapid identification of tumor antigens for the development of personalized immunotherapies

Valo Therapeutics Oy announces the exclusive licensing of intellectual property rights (IPR) from the University of Helsinki, Finland, for the institution’s innovative PeptiCHIP technology.

Successful completion of Series A for MedTech-startup PreciPoint

PreciPoint Group GmbH has successfully closed its Series A financing round of EUR 10 million. Existing investors, including bm-t beteiligungsmanagement thüringen gmbh (bm|t), and a new family office invested in the German MedTech startup.

Regeneron announces the 2022 winners of the Regeneron Prize for Creative Innovation

Regeneron Pharmaceuticals, Inc. today announced the winners of the 10th annual Regeneron Prize for Creative Innovation, a competition designed to recognize excellence and creativity in biomedical research conducted by postdoctoral fellows and graduate students.